• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dissecting the Tumor Microenvironment to Predict Immunotherapy Response in Hepatocellular Cancer.

作者信息

D'Alessio Antonio, Pinato David J

机构信息

Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom; Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

出版信息

Gastroenterology. 2022 Dec;163(6):1712-1713. doi: 10.1053/j.gastro.2022.08.024. Epub 2022 Aug 11.

DOI:10.1053/j.gastro.2022.08.024
PMID:35964689
Abstract
摘要

相似文献

1
Dissecting the Tumor Microenvironment to Predict Immunotherapy Response in Hepatocellular Cancer.剖析肿瘤微环境以预测肝细胞癌的免疫治疗反应
Gastroenterology. 2022 Dec;163(6):1712-1713. doi: 10.1053/j.gastro.2022.08.024. Epub 2022 Aug 11.
2
Immunotherapy in hepatocellular carcinoma.肝细胞癌的免疫治疗。
Rev Esp Enferm Dig. 2022 Nov;114(11):663-670. doi: 10.17235/reed.2022.8876/2022.
3
Cancer vaccines for hepatocellular carcinoma: future directions.用于肝细胞癌的癌症疫苗：未来方向
Immunotherapy. 2016;8(4):391-3. doi: 10.2217/imt-2015-0018.
4
The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook.肝细胞癌中的免疫抑制性肿瘤微环境：现状与展望。
Mol Immunol. 2022 Nov;151:218-230. doi: 10.1016/j.molimm.2022.09.010. Epub 2022 Sep 27.
5
Adoptive T-cell therapy to treat liver cancer: is the liver microenvironment key?过继性T细胞疗法治疗肝癌：肝脏微环境是关键因素吗？
Oncotarget. 2013 Aug;4(8):1117-8. doi: 10.18632/oncotarget.1179.
6
Learning the Roles of the Hepatic Adaptive Immune System in Hepatocellular Carcinoma-Nature's Guide for Successful Cancer Immunotherapy.了解肝脏适应性免疫系统在肝细胞癌中的作用——癌症免疫治疗成功的自然指南。
Semin Liver Dis. 2017 Aug;37(3):210-218. doi: 10.1055/s-0037-1606255. Epub 2017 Aug 28.
7
[Progress in immunotherapy for hepatocellular carcinoma].[肝细胞癌免疫治疗的进展]
Sheng Wu Gong Cheng Xue Bao. 2019 Dec 25;35(12):2326-2338. doi: 10.13345/j.cjb.190339.
8
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response.肝细胞癌的免疫治疗：炎症、纤维化和免疫反应之间的复杂界面。
J Immunother Cancer. 2019 Oct 18;7(1):267. doi: 10.1186/s40425-019-0749-z.
9
Nanomedicine Approach to Immunotherapy of Hepatocellular Carcinoma.纳米医学在肝细胞癌免疫治疗中的应用
J Biomed Nanotechnol. 2021 May 1;17(5):771-792. doi: 10.1166/jbn.2021.3055.
10
Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma.鉴定 HM13 作为肝细胞癌免疫治疗的预后指标和预测生物标志物。
BMC Cancer. 2022 Aug 13;22(1):888. doi: 10.1186/s12885-022-09987-2.

引用本文的文献

1
Pathologic assessment of hepatocellular carcinoma in the era of immunotherapy: a narrative review.免疫治疗时代肝细胞癌的病理评估：一篇叙述性综述
Hepatobiliary Surg Nutr. 2024 Jun 1;13(3):472-493. doi: 10.21037/hbsn-22-527. Epub 2023 Apr 4.
2
γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy.γδ T 细胞：在肝细胞癌免疫治疗的未来中具有变革意义。
Int J Mol Sci. 2024 Jan 23;25(3):1381. doi: 10.3390/ijms25031381.
3
Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches.
肥胖与肝癌发生的十字路口会议：独特的病理生理途径为创新治疗方法带来期望。
Int J Mol Sci. 2023 Sep 28;24(19):14704. doi: 10.3390/ijms241914704.
4
Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.鉴定胃癌中与铜死亡相关的亚型，构建预后模型和肿瘤微环境景观。
Front Immunol. 2022 Nov 21;13:1056932. doi: 10.3389/fimmu.2022.1056932. eCollection 2022.